October 2003 the UNIVERSITY of NEWCASTLE ANIMAL
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
PPE, Part 8 Sections 111 to 117, Part 9 Sections 118 to 122 of the Occupational Health and Safety Regulations
NORTHWEST TERRITORIES & NUNAVUT CODES OF PRACTICE In accordance with the Northwest Territories and Nunavut Safety Acts and Occupational Health and Safety Regulations PERSONAL PROTECTIVE EQUIPMENT BASICS Code of Practice PERSONAL PROTECTIVE EQUIPMENT BASICS NORTHWEST TERRITORIES WHAT IS A CODE OF PRACTICE? wscc.nt.ca The Workers’ Safety and Compensation Commission (WSCC) Yellowknife Box 8888, 5022 49th Street Codes of Practice (COP) provide practical guidance to achieve the Centre Square Tower, 5th Floor safety requirements of the Northwest Territories and Nunavut Yellowknife, NT X1A 2R3 Safety Acts and related Regulations. Telephone: 867-920-3888 Codes of Practice come into effect in each territory on the day Toll Free: 1-800-661-0792 they are published in the Northwest Territories Gazette and Fax: 867-873-4596 Nunavut Gazette. Toll Free Fax: 1-866-277-3677 Codes of Practice do not have the same legal force as the Acts, Inuvik Mining Regulations, Occupational Health and Safety Box 1188, 85 Kingmingya Road the or the Regulations. A person or employer cannot face prosecution for Blackstone Building, Unit 87 Inuvik, NT X0E 0T0 failing to comply with a COP. They are considered industry best practice and may be a consideration when determining whether Telephone: 867-678-2301 Safety Acts Fax: 867 -678-2302 an employer or worker has complied with the and Regulations in legal proceedings. NUNAVUT As per subsection 18(3) of the Northwest Territories and Nunavut wscc.nu.ca Safety Acts, “For the purpose of providing practical guidance with respect -
Code of Practice for Warehouse and Terminal Facilities Storing Hazardous Materials
Special Hazard Situations 169 ACKNOWLEDGMENT tion Service, 5285 Port Royal Rd., Springfield, Va. 22161). The authors would like to express their appreciation 3. Tanker Casualties Report. Imco No. 78.16E, Lon for the assistance provided by Steve Bailey of ICF, don, England, 1978. Incorporated, and Betty Alix, Dan Bower, Jo Ann 4. J .D. Porricelli and V.F. Keith. Tankers and the Grega, and Diana Rogers of Rensselaer Polytechnic U.S. Energy Situation: An Economic and Environ Institute. mental Analysis. In Marine Technology, Oct. 1974, pp. 340-364. ~ 5. N. Meade, T. LaPointe, and R. Anderson. Multi variate Analysis of Worldwide Tanker Casualties. REFERENCES Proc., Oil Spill 8th Conference, San Antonio, Tex., 1983, pp. 553-557. 1. J.J. Henry Company, Inc. An Analysis of Oil Out 6. M.A. Froelich and J.F. Bellantoni. Oil Spill flows Due to Tanker Accidents, 1971-72. Report Rates in Four U.S. Coastal Regions. Proc., 1981 AD-780315. U.S. Coast Guard, U.S. Department of Oil Spill Conference, American Petroleum Insti Transportation, Washington, o.c., Nov. 1973. tute, Washington, D.C., 1981, pp. 677-683. 2. Offshore Petroleum Transfer Systems for Washing 7. Polluting Incidents in and Around u. S. Waters, ton State: A Feasibility Study, Oceanographic Calendar Year 1981 and 1982. U.S. Coast Guard, Institute of Washington, Seattle, Dec. 19741 U .s. Department of Transportation, Washington, NTIS PB-244 945/2 (National Technical Informa- D.C., Dec. 1983. Code of Practice for Warehouse and Terminal Facilities Storing Hazardous Materials James F. LaMorte and Donald L. Williams ABSTRACT Practical standards are needed to guide the construction and operation of Canadian warehouses and transport terminals in which packaged hazardous mate rials are stored. -
7.2 Emergency Evacuation, Lockdown and Drills
7.2 EMERGENCY EVACUATION, LOCKDOWN AND DRILLS Policy Statement The Service recognises the timely and controlled response to emergency events, such as a fire, bomb threat or lockdown contributes significantly to upholding the safety and wellbeing of children, staff and any other relevant individuals onsite. The service is committed to ensuring safety of all relevant persons through sound preparation, rehearsal, evaluations and the actual undertaking of an emergency response. The Approved Provider also recognises their duties to comply with Education and Care Service Regulations 2011 (regulations 97 and 168 (2)(e)). The scope of this policy and procedure applies to both the: • the response to emergency events while on the school premises • the ongoing review, preparation and development of risk-assessed responses to emergency events Related Policies • 6.3 – Workplace Health and Safety • 8.10 – Employee Orientation and Induction Auxiliary Plans and Templates • 7.2.1 - Emergency Evacuation Plan • 7.2.3 - Bomb Threat Checklist • 7.2.2 - Lockdown Plan • 7.2.4 – Emergency Drill Evaluation Template Roles and Responsibilities Approved Provider • Ensuring policy and procedure provide all staff are instructed and trained in the emergency evacuation and lockdown plans. • Ensure emergency evacuation action plans have been developed through risk-assessment practices that identify potential emergencies. • Ensuring plans are displayed in a prominent location near entry and exit points. • Ensure emergency and evacuations plans are rehearsed and documented. • Ensure processes are developed to monitor the function and working order of fire equipment. Nominated Supervisor • Support the Approved Provider in facilitating the collaborative ongoing review and development of emergency and evacuation plans. -
The Effects of Antipsychotic Treatment on Metabolic Function: a Systematic Review and Network Meta-Analysis
The effects of antipsychotic treatment on metabolic function: a systematic review and network meta-analysis Toby Pillinger, Robert McCutcheon, Luke Vano, Katherine Beck, Guy Hindley, Atheeshaan Arumuham, Yuya Mizuno, Sridhar Natesan, Orestis Efthimiou, Andrea Cipriani, Oliver Howes ****PROTOCOL**** Review questions 1. What is the magnitude of metabolic dysregulation (defined as alterations in fasting glucose, total cholesterol, low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, and triglyceride levels) and alterations in body weight and body mass index associated with short-term (‘acute’) antipsychotic treatment in individuals with schizophrenia? 2. Does baseline physiology (e.g. body weight) and demographics (e.g. age) of patients predict magnitude of antipsychotic-associated metabolic dysregulation? 3. Are alterations in metabolic parameters over time associated with alterations in degree of psychopathology? 1 Searches We plan to search EMBASE, PsycINFO, and MEDLINE from inception using the following terms: 1 (Acepromazine or Acetophenazine or Amisulpride or Aripiprazole or Asenapine or Benperidol or Blonanserin or Bromperidol or Butaperazine or Carpipramine or Chlorproethazine or Chlorpromazine or Chlorprothixene or Clocapramine or Clopenthixol or Clopentixol or Clothiapine or Clotiapine or Clozapine or Cyamemazine or Cyamepromazine or Dixyrazine or Droperidol or Fluanisone or Flupehenazine or Flupenthixol or Flupentixol or Fluphenazine or Fluspirilen or Fluspirilene or Haloperidol or Iloperidone -
Theme Summary 9: Personal Protective Clothing and Equipment (Ppe)
ILO CONSTRUCTION OS&H A free, comprehensive, international, digital training package in occupational safety and health for the construction industry THEME SUMMARY 9: PERSONAL PROTECTIVE CLOTHING AND EQUIPMENT (PPE) Photo: Richard Neale. PPE provided by S&M, Cardiff, UK; www.sandmdecorating.co.uk Summary of content 1. Preface 2. The need for personal protective clothing and equipment (PPE) 3. General review of personal protective clothing and equipment 4. Clothing 5. Harnesses and similar devices 6. Lifting and handling devices 7. Specific characteristics of individuals 8. Summary photos of safe working 9. Relevant elements of the Knowledge Base Theme summary 9: Personal protective clothing and equipment 1 PREFACE This Theme Summary follows the relevant structure and content of the “ILO Code of Practice: Safety & health in construction” (the “Code”). The following passage is taken from this Code: “1. General provisions 1.1. Objective 1.1.1. The objective of this code is to provide practical guidance on a legal, administrative, technical and educational framework for safety and health in construction with a view to: (a) preventing accidents and diseases and harmful effects on the health of workers arising from employment in construction; (b) ensuring appropriate design and implementation of construction projects; (c) providing means of analysing from the point of view of safety, health and working conditions, construction processes, activities, technologies and operations, and of taking appropriate measures of planning, control and enforcement. 1.1.2. This code also provides guidance in the implementation of the provisions of the Safety and Health in Construction Convention, 1988 (No. 167), and the Safety and Health in Construction Recommendation, 1988 (No. -
Permit to Work Manual
Permit To Work Manual 30 December 2010 CS-PTW-01 Version 2.0 DOCUMENT CONTROL Document Details Document Reference/Name: CS-PTW-01 PTW Manual Version Number: V2.0 Documentation Status: Approved Document Owner: Corporate PTW Committee Document Approval: General Manager Operations Next Scheduled Review Date: December 2011 Version History Version Number Date Reason/Comments 0.00.01 12/12/03 Review Team Draft 0.00.02 30/01/04 First Consultation Draft - across sites 1.00.03 03/2004 Inclusion of site comments and approved for release 2.0 12/2010 Full review by Corporate PTW Committee Page i Permit To Work Manual FOREWARD Operating our business safely is CS Energy’s highest priority. We genuinely care about the health and safety of our employees and contractors who undertake maintenance and refurbishment task at our sites. We also recognise that completion of the tasks in a safe, timely and quality manner is the foundation for ensuring that CS Energy continues to generate electricity safely, reliably and economically. To achieve this, we use the Permit to Work System (PTW) to provide all workers safe access to plant and equipment. The PTW System is considered our primary safety system and is used widely across CS Energy’s sites. The PTW System ensures a high level of control and minimisation of risk in areas that contain energy. CS Energy’s PTW system has been developed to comply with the Generator’s Permit to Work Code of Practice. This Manual outlines the key elements of this system such as roles and responsibilities, procedures, training, reporting and monitoring activities. -
UKRIO Code of Practice for Research
UK Research Integrity Office Code of Practice For Research Promoting good practice and preventing misconduct Code of Practice for Research © 2009 and 2021 UK Research Integrity Office Recommended Checklist for Researchers The Checklist lists the key points of good practice for a research project and is applicable to all subject areas. More detailed guidance is available in Section 3. A PDF version is available from our website. Code of Practice for Research © 2009 and 2021 UK Research Integrity Office Contents RECOMMENDED CHECKLIST FOR RESEARCHERS .............................. inside front cover 1. INTRODUCTION ................................................................................................................. 1 2. PRINCIPLES ....................................................................................................................... 4 3. STANDARDS FOR ORGANISATIONS AND RESEARCHERS ......................................... 6 3.1 General guidance on good practice in research ........................................................ 6 3.2 Leadership and supervision ........................................................................................ 7 3.3 Training and mentoring ................................................................................................ 7 3.4 Research design ........................................................................................................... 8 3.5 Collaborative working ................................................................................................. -
Prohibited Substances List
Prohibited Substances List This is the Equine Prohibited Substances List that was voted in at the FEI General Assembly in November 2009 alongside the new Equine Anti-Doping and Controlled Medication Regulations(EADCMR). Neither the List nor the EADCM Regulations are in current usage. Both come into effect on 1 January 2010. The current list of FEI prohibited substances remains in effect until 31 December 2009 and can be found at Annex II Vet Regs (11th edition) Changes in this List : Shaded row means that either removed or allowed at certain limits only SUBSTANCE ACTIVITY Banned Substances 1 Acebutolol Beta blocker 2 Acefylline Bronchodilator 3 Acemetacin NSAID 4 Acenocoumarol Anticoagulant 5 Acetanilid Analgesic/anti-pyretic 6 Acetohexamide Pancreatic stimulant 7 Acetominophen (Paracetamol) Analgesic/anti-pyretic 8 Acetophenazine Antipsychotic 9 Acetylmorphine Narcotic 10 Adinazolam Anxiolytic 11 Adiphenine Anti-spasmodic 12 Adrafinil Stimulant 13 Adrenaline Stimulant 14 Adrenochrome Haemostatic 15 Alclofenac NSAID 16 Alcuronium Muscle relaxant 17 Aldosterone Hormone 18 Alfentanil Narcotic 19 Allopurinol Xanthine oxidase inhibitor (anti-hyperuricaemia) 20 Almotriptan 5 HT agonist (anti-migraine) 21 Alphadolone acetate Neurosteriod 22 Alphaprodine Opiod analgesic 23 Alpidem Anxiolytic 24 Alprazolam Anxiolytic 25 Alprenolol Beta blocker 26 Althesin IV anaesthetic 27 Althiazide Diuretic 28 Altrenogest (in males and gelidngs) Oestrus suppression 29 Alverine Antispasmodic 30 Amantadine Dopaminergic 31 Ambenonium Cholinesterase inhibition 32 Ambucetamide Antispasmodic 33 Amethocaine Local anaesthetic 34 Amfepramone Stimulant 35 Amfetaminil Stimulant 36 Amidephrine Vasoconstrictor 37 Amiloride Diuretic 1 Prohibited Substances List This is the Equine Prohibited Substances List that was voted in at the FEI General Assembly in November 2009 alongside the new Equine Anti-Doping and Controlled Medication Regulations(EADCMR). -
Code of Practice
HOW TO MANAGE WORK HEALTH AND SAFETY RISKS Code of Practice DECEMBER 2011 Safe Work Australia is an Australian Government statutory agency established in 2009. Safe Work Australia consists of representatives of the Commonwealth, state and territory governments, the Australian Council of Trade Unions, the Australian Chamber of Commerce and Industry and the Australian Industry Group. Safe Work Australia works with the Commonwealth, state and territory governments to improve work health and safety and workers’ compensation arrangements. Safe Work Australia is a national policy body, not a regulator of work health and safety. The Commonwealth, states and territories have responsibility for regulating and enforcing work health and safety laws in their jurisdiction. NSW note: This code of practice has been approved under section 274 of the Work Health and Safety Act 2011. Notice of that approval was published in the NSW Government Gazette referring to this code of practice as How to manage work health and safety risks (page 7194) on Friday 16 December 2011. This code of practice commenced on 1 January 2012. ISBN 978-0-642-33301-8 [PDF] ISBN 978-0-642-33302-5 [RTF] Creative Commons Except for the logos of Safe Work Australia, SafeWork SA, Workplace Standards Tasmania, WorkSafe WA, Workplace Health and Safety QLD, NT WorkSafe, WorkCover NSW, Comcare and WorkSafe ACT, this copyright work is licensed under a Creative Commons Attribution-Noncommercial 3.0 Australia licence. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/3.0/au/ In essence, you are free to copy, communicate and adapt the work for non commercial purposes, as long as you attribute the work to Safe Work Australia and abide by the other licence terms. -
Curable Composition and Skin Adhesive
(19) TZZ ¥Z¥_T (11) EP 2 957 303 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 23.12.2015 Bulletin 2015/52 A61L 15/58 (2006.01) A61L 24/04 (2006.01) C08K 5/10 (2006.01) C09J 167/06 (2006.01) (2006.01) (21) Application number: 14173247.9 C08L 67/06 (22) Date of filing: 20.06.2014 (84) Designated Contracting States: (72) Inventor: Schüwer, Nicolas AL AT BE BG CH CY CZ DE DK EE ES FI FR GB 1010 Lausanne (CH) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (74) Representative: Hoffmann Eitle Designated Extension States: Patent- und Rechtsanwälte PartmbB BA ME Arabellastraße 30 81925 München (DE) (71) Applicant: NITTO DENKO CORPORATION Osaka 567 (JP) (54) Curable composition and skin adhesive (57) The present invention pertains to compositions The composition of the invention may be cross- linked to containing a polycondensate and optionally an oil com- yield an adhesive composition. The composition of the ponent, wherein the polycondensate is derived from a invention and the adhesive composition of the invention dicarboxylic acid component, a diol component and an may be used on substrates such as tapes and patches ethylenically unsaturated dicarboxylic acid component. in the medical field. EP 2 957 303 A1 Printed by Jouve, 75001 PARIS (FR) EP 2 957 303 A1 Description 1. Technical Field of the Invention 5 [0001] The present invention relates to a curable composition comprising: a polycondensate of a dicarboxylic acid, a diol, and a polymerizable ethylenic derivative; and optionally an oil additive. -
Anesthesia and Analgesia in Laboratory Animals
GUIDELINES ON ANESTHESIA AND ANALGESIA IN LABORATORY ANIMALS University of South Florida provides the following guidelines for use by IACUC-certified faculty and staff. CONTENTS PAGE A. Background……………………………………………………….…………………………… 1 B. Definitions....……………………………………………………..…………………………….. 2 C. General Considerations……………………………………….,…………………………….. 3 D. Controlled Substances……………………………………….……………………………… 3 E. Pre-Anesthetic Treatments………………………………….………………………………. 4 F. General Anesthetics………………………………………….………………………………. 4 G. Neuromuscular Blocking Agents………………………….……………………………….. 5 H. Monitoring Anesthesia…………………………………….…………………………………. 6 I. Analgesics……………………………………………………………………………………… 7 J. Comments regarding Anesthetics and Analgesics……………………………………... 7 REFERENCE TABLES PAGE I. Signs of Pain and Distress in Laboratory Animals………………………………………… 10 II. Commonly Used Anesthetics and Analgesics for Mice….………..…...….………...…… 11 III. Commonly Used Anesthetics and Analgesics for Rats……………………………...…… 12 IV. Commonly Used Anesthetics and Analgesics for Gerbils……….……………..…….. 13 V. Commonly Used Anesthetics and Analgesics for Hamsters…….……………..……. 14 VI. Commonly Used Anesthetics and Analgesics for Guinea Pigs….…………….….……. 15 VII. Commonly Used Anesthetics and Analgesics for Rabbits.……...…………….………… 16 VIII. Commonly Used Anesthetics and Analgesics for Dogs.…………………….…………… 17 IX. Commonly Used Anesthetics and Analgesics for Cats.……………………..…………… 18 X. Commonly Used Anesthetics and Analgesics for Pigs ..……………..….………………..19 XI. Commonly Used Anesthetics and Analgesics -
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
WHO/PSM/QSM/2006.3 The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances 2006 Programme on International Nonproprietary Names (INN) Quality Assurance and Safety: Medicines Medicines Policy and Standards The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 © World Health Organization 2006 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.